Luan, Xiaoyu
Chen, Peng
Li, Yaxin
Yuan, Xinying
Miao, Longyu
Zhang, Pengyu
Cao, Qilong
Song, Xiaomin
Di, Guohu http://orcid.org/0000-0001-9940-730X
Funding for this research was provided by:
National Key R&D Program of China Grants (2018YFA0109800)
Postdoctoral Research Foundation of China (No.2019M652328)
Shandong Provincial Natural Science Foundation grant (ZR2022MH183)
Article History
Received: 22 November 2022
Accepted: 14 April 2023
First Online: 24 April 2023
Declarations
:
: All animal studies were performed in accordance with the regulations of the ARRIVE guidelines and approved by the Ethics Committee at the Medical College of Qingdao University (Title, Therapeutic effect and molecular mechanisms of TNF-α/IL-1β pretreated MSCs on liver injury and fibrosis; Approval document of Ethics Committee, Medical College of Qingdao University; Approval Reference No.QDU-AEC-2021165; Date, December 14, 2021).
: Not applicable.
: The authors declare that they have no competing interests. Qingdao Haier Biotech Co. Ltd. did not provide any product or service to this study.